Integrative Transcriptomic, Network, and Machine Learning Analyses Identify Genistein and Resveratrol-Associated Therapeutic Targets in Alzheimer's Disease.
Overview
- Faculty of Science, Department of Molecular Biology and Genetics, Atatürk University,Erzurum, Türkiye
- East Anatolian High Technology Research and Application Center (DAYTAM), Atatürk University,Erzurum, 25240 Türkiye
- Department of Pharmacy Services, Nihat Delibalta Göle Vocational High School, Ardahan University,Ardahan, 75700 Türkiye
- Faculty of Science, Department of Chemistry, Atatürk University,Erzurum, Türkiye
Abstract
Alzheimer’s disease (AD) is a multifactorial neurodegenerative disorder characterized by complex molecular alterations across multiple brain regions. In this study, we applied an integrative systems-level framework combining multi-region transcriptomic analysis, protein–protein interaction (PPI) network topology, machine learning–based validation, and in silico approaches to identify robust and pharmacologically relevant molecular targets in AD. Gene expression data from four AD-related brain regions (entorhinal cortex, frontal cortex, hippocampus, and temporal cortex) were obtained from the GSE5281 dataset, yielding 467 genes consistently dysregulated across all regions. Network analysis identified a subset of downregulated hub genes predominantly associated with mitochondrial bioenergetics and proteostasis pathways. Intersection with experimentally curated targets of genistein and resveratrol prioritized four elite genes, COX5B, ENO1, HSP90AB1, and SDHB as shared and biologically central nodes. To assess the collective discriminative capacity of the identified gene set, a random forest classifier was trained using shared differentially expressed genes. The model demonstrated strong classification performance with a low out-of-bag error rate, while feature importance analysis identified SDHB as the most influential contributor, followed by COX5B and ENO1, indicating synergistic multigene effects rather than isolated biomarker behavior. Machine learning was applied as an integrative validation layer to reinforce biological relevance, rather than as a standalone diagnostic tool. Finally, molecular docking analyses revealed favorable binding affinities of genistein and resveratrol toward all four elite targets. Overall, these findings highlight a convergent mitochondrial–proteostas
Supplementary Information: The online version contains supplementary material available at 10.1007/
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper links to its data, not to its authors' code: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- ncbi.nlm.nih.gov/
geo2r — at NCBI; found in the text, “Data Processing and Target Identification”
Other data links
- ncbi.nlm.nih.gov/
geo — NCBI; found in the text, “Data Collection”
Data Availability
All data used in this study are available in the GEO repository. Data are available from the corresponding author upon reasonable request.
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 2, 28 September 2026
- Publisher: — → Springer Science+Business Media
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 3 authors, 5 keywords, 9 MeSH terms, 1 funder, 53 references.
Cite
This paper
Isıyel, M., Ceylan, H., & Demir, Y. (2026). Integrative Transcriptomic, Network, and Machine Learning Analyses Identify Genistein and Resveratrol-Associated Therapeutic Targets in Alzheimer's Disease. Molecular neurobiology, 63(1), 666. https://
BibTeX
@article{isyel2026integr
author = {Isıyel, Murat and Ceylan, Hamid and Demir, Yeliz},
title = {{Integrative Transcriptomic, Network, and Machine Learning Analyses Identify Genistein and Resveratrol-Associated Therapeutic Targets in Alzheimer's Disease}},
journal = {Molecular neurobiology},
year = {2026},
month = jun,
volume = {63},
number = {1},
pages = {666},
publisher = {Springer Science+Business Media},
issn = {0893-7648},
doi = {10.1007/
url = {https://
pmid = {42228255},
pmcid = {PMC13230253}
}
RIS
TY - JOUR
AU - Isıyel, Murat
AU - Ceylan, Hamid
AU - Demir, Yeliz
TI - Integrative Transcriptomic, Network, and Machine Learning Analyses Identify Genistein and Resveratrol-Associated Therapeutic Targets in Alzheimer's Disease
T2 - Molecular neurobiology
J2 - Mol Neurobiol
PY - 2026
DA - 2026/
VL - 63
IS - 1
SP - 666
SN - 0893-7648
PB - Springer Science+Business Media
DO - 10.1007/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1007/
"type": "article-journal",
"title": "Integrative Transcriptomic, Network, and Machine Learning Analyses Identify Genistein and Resveratrol-Associated Therapeutic Targets in Alzheimer's Disease",
"container-title": "Molecular neurobiology",
"author": [
{
"family": "Isıyel",
"given": "Murat"
},
{
"family": "Ceylan",
"given": "Hamid"
},
{
"family": "Demir",
"given": "Yeliz"
}
],
"container-title-short":
"volume": "63",
"issue": "1",
"page": "666",
"DOI": "10.1007/
"PMID": "42228255",
"PMCID": "PMC13230253",
"ISSN": "0893-7648",
"publisher": "Springer Science+Business Media",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
6,
2
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1186/s13293-026-00930-9
- Early, sex-dependent and progressive proteomic imbalance in the amygdala during Alzheimer´s disease continuum.Journal: Biology of sex differencesIn common: Alzheimer's / dementia, genetics / omics, 3 references
- [2] doi:10.34133/csbj.0134 [code]
- Integrated Multi-Tissue Transcriptomics Reveals Antagonistic Pleiotropy in Aging and Alzheimer's Disease.Journal: Computational and structural biotechnology journalIn common: Alzheimer's / dementia, genetics / omics, cellular / molecular, 2 references
- [3] doi:10.1523/eneuro.0468-25.2026 [code]
- A Multi-Network Approach Identifies Proteins Related to Dendritic Spines in Alzheimer's Disease.Journal: eNeuroIn common: Alzheimer's / dementia, genetics / omics, 2 references
- [4] doi:10.1038/s41467-026-74037-5
- Microglial CD31 suppresses Aβ clearance and promotes Alzheimer pathology in 5×FAD mice.Journal: Nature communicationsIn common: Alzheimer's / dementia, cellular / molecular, 2 references
- [5] doi:10.3389/fnins.2026.1771310
- Oleic acid improves pathological changes in Aβ1-42-induced astrocytes and Alzheimer's disease mouse models through PKA/
ACACB/ CPT1A. Journal: Frontiers in neuroscienceIn common: Alzheimer's / dementia, cellular / molecular, 2 references - [6] doi:10.1007/s10571-026-01726-6
- Gene Expression Analysis of Mitochondria-Associated Membrane (MAM)-Related Genes in ER Stress and Alzheimer's Disease.Journal: Cellular and molecular neurobiologyIn common: Alzheimer's / dementia, genetics / omics, cellular / molecular, 2 references
- [7] doi:10.1038/s41467-026-73996-z [code]
- Genetic architecture of white matter microstructure captured by unsupervised deep representation learning of fractional anisotropy maps.Journal: Nature communicationsIn common: genetics / omics, cellular / molecular, 2 references
- [8] doi:10.1038/s41598-026-56101-8
- Topological modeling of gene expression in the brain with Huntington's disease reveals selective disruption of co-expression network.Journal: Scientific reportsIn common: genetics / omics, cellular / molecular, 2 references
- [9] doi:10.1186/s40035-026-00567-z
- Transaldolase 1 contributes to pentose phosphate pathway disruption and synaptic dysfunction in Alzheimer's disease.Journal: Translational neurodegenerationIn common: Alzheimer's / dementia, genetics / omics, cellular / molecular, 1 reference
- [10] doi:10.1038/s41398-026-04199-9 [code]
- Immune cell-specific genetic architecture of Alzheimer's disease revealed by multi-omics analysis for therapeutic target discovery and prioritization.Journal: Translational psychiatryIn common: Alzheimer's / dementia, genetics / omics, cellular / molecular, 1 reference
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.
Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
